MXD4 and acute myeloid leukemia: Our data showed that PKC412-mediated inhibition of FLT3 signaling increased Mxd1 and Mxd2 expression, as well as the expression of Mxd4 and Mnt to a lesser degree, while it reduced cMyc expression in Flt3-ITD AML cells.